No Data
No Data
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
Lake Street Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $3
Assertio Therapeutics: Strong Buy Rating on Robust Portfolio and Strategic Growth
Assertio Therapeutics: A Strong Buy on Robust Financial Performance and Strategic Growth Potential
Assertio Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
No Data
No Data
White_Shadow OP : love this stock, way undervalued